Studies home breathing machine data to spot early COPD flare-ups
Uses data from home breathing machines to look for early signs of COPD worsening.
Plain-language title generated from the registry record
Registry title: Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices
Key facts
- Where
- Sabadell, SpainSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 80 years old?
Source: NCT07267104, who can take part
Where in Spain
- Corporation Parc Tauli de SabadellSabadell, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Corporacion Parc Tauli
- Trial code
- NCT07267104
- Record updated
- 5 December 2025
- Original description
This study will look at people with COPD who use a home breathing machine called non-invasive ventilation (NIV). NIV machines collect information about your breathing, such as air flow, pressure, and mask leaks.Read full original descriptionShow less
SAGE-NIV: Surveillance and Artificial Intelligence Guidance for Exacerbations in COPD Patients With Home Non-Invasive Ventilation
This study will look at people with COPD who use a home breathing machine called non-invasive ventilation (NIV). NIV machines collect information about your breathing, such as air flow, pressure, and mask leaks.
Researchers want to use a computer program, called artificial intelligence (AI), to study this information. The goal is to find early signs that your breathing may be getting worse.
People with COPD who already use NIV at home may join this study. The study does not change your treatment. It only uses the breathing data already recorded by your NIV machine.
The computer program will look for patterns in the data. These patterns may help doctors:
Notice early warning signs of a COPD flare-up Find problems with how you and the machine work together Improve the way NIV is monitored at home The main goal is to create a tool that helps patients and doctors manage home NIV more easily and more safely.
Inclusion: Age between 40 and 80 years; COPD diagnosed by pulmonary function tests; Home NIV therapy with good adherence (minimum daily compliance > 5 hours) for at least 6 months; Users of the ResMed LUMIS 150 ventilator. This is due to the presence of the decoding tool and a larger storage capacity (more than 100 nights) in the removable device of the ventilator; Acute exacerbation requiring hospital admission or home care.
Exclusion: Previous clinical instability defined by the need for antibiotics and/or systemic corticosteroids in the two months prior to the inclusion exacerbation, excluding the 48 hours prior to admission, as this was considered part of the inclusion clinical picture; Lack of informed consent.